The Fortis Life Sciences® team is excited to meet you at the AACR Annual Meeting! Learn about our solutions for oncology R&D, diagnostics, and therapeutics.
Fortis Life Sciences Brands at AACR 2024
Visit our poster presented by Danielle Fails: Cyclic immunofluorescent analysis of the tumor microenvironment across human brain cancer subtypes
- Monday, April 10, 9:30am–12:30pm
- Session: Immune Cells in the Tumor Microenvironment 2
- Location: Section 9, Poster board 20
- Abstract #6876
Resources
Antibodies for Oncology Research
Browse our catalog of highly validated antibodies for identifying immune cell and tumor markers, T-cell markers and immune checkpoints.
VHH (Single-domain Antibody) Discovery
Abcore offers an off-the-shelf naïve VHH library as well as custom VHH discovery services. The downstream applications of each differ. Reach out to our team to discuss which AbNano™ offering meets your project needs.
Antibodies and Antigens for Cancer Diagnostics
We offer a wide variety of cancer marker antibodies and antigens that are functionally tested for use in lateral flow assays.
Nanoparticles for Cancer Therapy
Our proprietary nanoparticle manufacturing techniques provide solutions for the rapid development and commercialization of medical devices and therapeutic products. Our expertise covers a range of services for targeted delivery, photothermal therapy, biofunctionalization and more.
Focus on Immuno-oncology and Immunotherapy
For over 100 years, long before the cells that make up the immune system were identified and characterized, scientists have been attempting to harness their understanding of the immune system to target cancer.
Focus on Metastasis
Our proprietary nanoparticle manufacturing techniques provide solutions for the rapid development and commercialization of medical devices and therapeutic products. Our expertise covers a range of services for targeted delivery, photothermal therapy, biofunctionalization and more.